The Impact of Lenalidomide, Bortezomib, and Dexamethasone Treatment on Health-Related Quality of Life in Transplant-Eligible Patients with Newly-Diagnosed Multiple Myeloma: Results from the IFM/DFCI 2009 Trial

被引：3

作者：

Roussel, Murielle ^{[1
,2
]}

Hebraud, Benjamin ^{[1
,2
]}

Hulin, Cyrille ^{[3
]}

Perrot, Aurore ^{[4
]}

Caillot, Denis ^{[5
]}

Macro, Margaret ^{[6
]}

Arnulf, Bertrand ^{[7
]}

Belhadj, Karim ^{[8
]}

Garderet, Laurent ^{[9
]}

Facon, Thierry ^{[10
]}

Guo, Shien ^{[11
]}

Altincatal, Arman ^{[11
]}

Dhanasiri, Sujith ^{[12
]}

Leleu, Xavier ^{[10
]}

Moreau, Philippe ^{[13
]}

Attal, Michel ^{[1
,2
]}

机构：

[1] Inst Univ Canc, Toulouse, France

[2] Univ Hosp, Toulouse, France

[3] Ctr Hosp Univ, Bordeaux, France

[4] Univ Lorraine, CHU Nancy, Nancy, France

[5] CHU Dijon, Hop Bocage, Dijon, France

[6] CHU Caen, Hop Cote Nacre, Caen, France

[7] Hop St Louis, APHP, Paris, France

[8] Ctr Hosp Univ Henri Mondor, Creteil, France

[9] Hop St Antoine, Paris, France

[10] CHRU Lille, Hop Claude Huriez, Lille, France

[11] Evidera, Waltham, MA USA

[12] Celgene Int, Boudry, Switzerland

[13] Nantes Univ Hosp, Nantes, France

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-111477

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

716

引用

页数：4

共 50 条

[1] Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
Roussel, Murielle
Hebraud, Benjamin
Hulin, Cyrille
Perrot, Aurore
Caillot, Denis
Stoppa, Anne-Marie
Macro, Margaret
Escoffre, Martine
Arnulf, Bertrand
Belhadj, Karim
Karlin, Lionel
Garderet, Laurent
Facon, Thierry
Guo, Shien
Weng, Josh
Dhanasiri, Sujith
Leleu, Xavier
Moreau, Philippe
Attal, Michel
LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1323 - 1333
[2] Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
Voorhees, Peter M.
Kaufman, Jonathan L.
Laubach, Jacob
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Silbermann, Rebecca
Costa, Luciano J.
Anderson, Larry D., Jr.
Nathwani, Nitya
Shah, Nina
Efebera, Yvonne A.
Holstein, Sarah A.
Costello, Caitlin
Jakubowiak, Andrzej
Wildes, Tanya M.
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Murphy, Sean
Lutska, Yana
Pei, Huiling
Ukropec, Jon
Vermeulen, Jessica
de Boer, Carla
Hoehn, Daniela
Lin, Thomas S.
Richardson, Paul G.
BLOOD, 2020, 136 (08) : 936 - 945
[3] Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone: Patient Reported Outcomes from GRIFFIN
Silbermann, Rebecca
Laubach, Jacob
Kaufman, Jonathan L.
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Costa, Luciano J.
Anderson, Larry D.
Nathwani, Nitya
Shah, Nina
Bumma, Naresh
Holstein, Sarah A.
Costello, Caitlin
Jakubowiak, Andrzej
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Gries, Katharine S.
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Lin, Thomas S.
Richardson, Paul G.
Usmani, Saad
Voorhees, Peter M.
BLOOD, 2022, 140 : 1146 - 1149
[4] Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN
Silbermann, Rebecca
Laubach, Jacob
Kaufman, Jonathan L.
Sborov, Douglas W.
Reeves, Brandi
Rodriguez, Cesar
Chari, Ajai
Costa, Luciano J.
Anderson, Larry D.
Nathwani, Nitya
Shah, Nina
Bumma, Naresh
Holstein, Sarah A.
Costello, Caitlin
Jakubowiak, Andrzej
Orlowski, Robert Z.
Shain, Kenneth H.
Cowan, Andrew J.
Gries, Katharine S.
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Lin, Thomas S.
Voorhees, Peter M.
Usmani, Saad Z.
Richardson, Paul G.
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1257 - 1268
[5] Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
Kazuhito Suzuki
Nobuhiro Tsukada
Noriko Nishimura
Yasuyuki Nagata
Kiyoshi Okazuka
Yuko Mishima
Masahiro Yokoyama
Kaichi Nishiwaki
Tadao Ishida
Shingo Yano
Yasuhito Terui
Kenshi Suzuki
International Journal of Hematology, 2020, 111 : 103 - 111
[6] Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
Nooka, Ajay K.
Kaufman, Jonathan L.
Rodriguez, Cesar
Jakubowiak, Andrzej
Efebera, Yvonne
Reeves, Brandi
Wildes, Tanya
Holstein, Sarah A.
Anderson, Larry D., Jr.
Badros, Ashraf
Shune, Leyla
Chari, Ajai
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Bartlett, J. Blake
Vermeulen, Jessica
Lin, Thomas S.
Richardson, Paul G.
Voorhees, Peter
BLOOD CANCER JOURNAL, 2022, 12 (04)
[7] Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
Ajay K. Nooka
Jonathan L. Kaufman
Cesar Rodriguez
Andrzej Jakubowiak
Yvonne Efebera
Brandi Reeves
Tanya Wildes
Sarah A. Holstein
Larry D. Anderson
Ashraf Badros
Leyla Shune
Ajai Chari
Huiling Pei
Annelore Cortoos
Sharmila Patel
J. Blake Bartlett
Jessica Vermeulen
Thomas S. Lin
Paul G. Richardson
Peter Voorhees
Blood Cancer Journal, 12
[8] The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
Okazuka, Kiyoshi
Ishida, Tadao
Nashimoto, Junichiro
Uto, Yui
Sato, Kota
Miyazaki, Kanji
Ogura, Mizuki
Yoshiki, Yumiko
Abe, Yu
Tsukada, Nobuhiro
Suzuki, Kenshi
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (02) : 110 - 115
[9] Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
Suzuki, Kazuhito
Tsukada, Nobuhiro
Nishimura, Noriko
Nagata, Yasuyuki
Okazuka, Kiyoshi
Mishima, Yuko
Yokoyama, Masahiro
Nishiwaki, Kaichi
Ishida, Tadao
Yano, Shingo
Terui, Yasuhito
Suzuki, Kenshi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (01) : 103 - 111
[10] Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: A multicenter retrospective comparative analysis
Nishimura, Noriko
Suzuki, Kazuhito
Tsukada, Nobuhiro
Nagata, Yasuyuki
Okaduka, Kiyoshi
Mishima, Yuko
Yokoyama, Masahiro
Nishiwaki, Kaichi
Ishida, Tadao
Yano, Shingo
Terui, Yasuhito
Suzuki, Kenshi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E214 - E215

← 1 2 3 4 5 →